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MPTP treatment is a widely validated model to produce experimental parkinson-
ism. Among different administration protocols, chronic exposure to little amounts 
of MPTP has been reported to reproduce neuropathological features characterizing 
dopaminergic neurons in human Parkinson disease [1]. Recent studies by our group 
have found that MPTP, besides dopaminergic neurons, affects also spinal motor neu-
rons [2], thus bridging, at neuropathological level, Parkinson disease and Amyo-
trophic Lateral Sclerosis. 
In the present study we show that chronic MPTP treatment, as well as acute one, 
is able to induce motor neurons loss in lumbar spinal cord. We have investigated 
the involvement of autophagy and the occurrence of alterations in alpha-synucle-
in immunostaining, after MPTP treatment. The activation of autophagic pathway is 
proved by the significant increase of MAP LC3β in the motor neurons of MPTP treat-
ed mice. The same neurons possess altered alpha-synuclein immunostaining, detected 
by two novel homemade monoclonal antibodies. 
Motor neuron pathology could depend on direct effect of MPTP, but it can be also 
due to a remodeling in anatomical connections of motor neurons with descending 
pathways or intra-spinal networks. Among these, we have particularly investigated 
the Renshaw cells and the coeruleo-spinal noradrenaline projections, which can inter-
vene in both physiology and survival of motor neurons [3].
Our result shed new light on the physiopathology of motor symptoms in par-
kinsonism and call for novel pharmacological and neurophysiological approaches to 
relive motor function in Parkinson disease, through modulation of spinal circuits.
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